1. A Novel Physiologically Based Model of Creatinine Renal Disposition to Integrate Current Knowledge of Systems Parameters and Clinical Observations. (22nd May 2020) Authors: Scotcher, Daniel; Arya, Vikram; Yang, Xinning; Zhao, Ping; Zhang, Lei; Huang, Shiew‐Mei; Rostami‐Hodjegan, Amin; Galetin, Aleksandra Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 9:Number 6(2020) Page Start: 310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A12 - Mechanistic kidney models for creatinine: Relevance of OCT2 transport driving force to prediction of creatinine-drug interactions. (2020) Authors: Scotcher, Daniel; Arya, Vikram; Yang, Xinning; Zhao, Ping; Zhang, Lei K.; Huang, Shiew-Mei; Rostami-Hodjegan, Amin; Galetin, Aleksandra Journal: Drug metabolism and pharmacokinetics Issue: Volume 35(2020)Supplement 1 Page Start: S22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Advancing Predictions of Tissue and Intracellular Drug Concentrations Using In Vitro, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches. Issue 5 (12th September 2018) Authors: Guo, Yingying; Chu, Xiaoyan; Parrott, Neil J.; Brouwer, Kim L.R.; Hsu, Vicky; Nagar, Swati; Matsson, Pär; Sharma, Pradeep; Snoeys, Jan; Sugiyama, Yuichi; Tatosian, Daniel; Unadkat, Jashvant D.; Huang, Shiew‐Mei; Galetin, Aleksandra Other Names: Hoeben Eef investigator.; Chen Dapeng investigator.; Hartmann Georgy investigator.; Menzel Karsten investigator. Journal: Clinical pharmacology & therapeutics Issue: Volume 104:Issue 5(2018) Page Start: 865 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Application of a gut–liver-on-a-chip device and mechanistic modelling to the quantitative in vitro pharmacokinetic study of mycophenolate mofetil. Issue 15 (14th July 2022) Authors: Milani, Nicoló; Parrott, Neil; Ortiz Franyuti, Daniela; Godoy, Patricio; Galetin, Aleksandra; Gertz, Michael; Fowler, Stephen Journal: Lab on a chip Issue: Volume 22:Issue 15(2022) Page Start: 2853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC Perspective. Issue 3 (21st June 2022) Authors: Chu, Xiaoyan; Prasad, Bhagwat; Neuhoff, Sibylle; Yoshida, Kenta; Leeder, James Steven; Mukherjee, Dwaipayan; Taskar, Kunal; Varma, Manthena V. S.; Zhang, Xinyuan; Yang, Xinning; Galetin, Aleksandra Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 3(2022) Page Start: 501 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug‐Drug Interaction Evaluation: Perspectives From the International Transporter Consortium. Issue 5 (22nd October 2018) Authors: Chu, Xiaoyan; Liao, Mingxiang; Shen, Hong; Yoshida, Kenta; Zur, Arik A.; Arya, Vikram; Galetin, Aleksandra; Giacomini, Kathleen M.; Hanna, Imad; Kusuhara, Hiroyuki; Lai, Yurong; Rodrigues, David; Sugiyama, Yuichi; Zamek‐Gliszczynski, Maciej J.; Zhang, Lei Journal: Clinical pharmacology & therapeutics Issue: Volume 104:Issue 5(2018) Page Start: 836 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Coproporphyrin I as an Endogenous Biomarker to Detect Reduced OATP1B Activity and Shift in Elimination Route in Chronic Kidney Disease. Issue 3 (28th June 2022) Authors: Takita, Hiroyuki; Scotcher, Daniel; Chu, Xiaoyan; Yee, Ka Lai; Ogungbenro, Kayode; Galetin, Aleksandra Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 3(2022) Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Dabigatran Etexilate and Digoxin: Comparison as Clinical Probe Substrates for Evaluation of P‐gp Inhibition. Issue 5 (21st September 2018) Authors: Chu, Xiaoyan; Galetin, Aleksandra; Zamek‐Gliszczynski, Maciej J.; Zhang, Lei; Tweedie, Donald J. Journal: Clinical pharmacology & therapeutics Issue: Volume 104:Issue 5(2018) Page Start: 788 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Effect of Chronic Kidney Disease on Nonrenal Elimination Pathways: A Systematic Assessment of CYP1A2, CYP2C8, CYP2C9, CYP2C19, and OATP. Issue 5 (9th October 2017) Authors: Tan, Ming‐Liang; Yoshida, Kenta; Zhao, Ping; Zhang, Lei; Nolin, Thomas D.; Piquette‐Miller, Micheline; Galetin, Aleksandra; Huang, Shiew‐Mei Journal: Clinical pharmacology & therapeutics Issue: Volume 103:Issue 5(2018) Page Start: 854 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Effect of Chronic Kidney Disease on the Renal Secretion via Organic Anion Transporters 1/3: Implications for Physiologically‐Based Pharmacokinetic Modeling and Dose Adjustment. Issue 3 (13th June 2022) Authors: Tan, Shawn Pei Feng; Scotcher, Daniel; Rostami‐Hodjegan, Amin; Galetin, Aleksandra Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 3(2022) Page Start: 643 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗